Citigroup »

Zenas Biopharma shares owned by Citigroup

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $193k 9.9k 19.55
2025-03-31 $85k 11k 7.90
2024-12-31 $99k 12k 8.19

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Zenas Biopharma

FMR
Sr One Capital Management
NEA Management Company
Enavate Sciences GP
Federated Investors
Capital Research and Management Company - Division 3
Fairmount Funds Management
BlackRock
NVP Associates
Vanguard Group
Vanguard Capital Management
Polar Capital Holdings
Alliancebernstein
Wellington Management Company
EcoR1 Capital

View all funds holding Zenas Biopharma